Skip to main content

Aquestive Therapeutics, Inc.

AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001398733

In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Aquestive Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of AQST: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders1172114−1
Shares46.8M123.6K43.4M−3.27M (−7.0%)
Value$232.4M$614.8K$154.4M−$77.4M (−33.4%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (21)

Institutions that held Aquestive Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to AQST in Q4 2024
InstitutionSharesValue% of portfolio
Stonepine Capital Management, LLC160,000$569.6K0.46%
Raymond James Financial Inc139,591$497.7K0.00%
Marshall Wace, LLP55,695$198.3K0.00%
MONECO Advisors, LLC43,900$156.3K0.02%
HRT Financial LP42,176$150.0K0.00%
SBI Securities Co., Ltd.32,348$115.2K0.00%
State of Wisconsin Investment Board25,010$89.0K0.00%
China Universal Asset Management Co., Ltd.19,333$68.8K0.01%
PKS Advisory Services, LLC17,650$62.8K0.02%
Police & Firemen's Retirement System of New Jersey17,522$62.4K0.00%
Two Sigma Advisers, LP16,000$57.0K0.00%
Dynamic Technology Lab Private Ltd12,419$44.0K0.01%
Clear Street Markets LLC6,666$23.7K0.01%
State of Wyoming5,229$18.6K0.00%
Mirae Asset Global Investments Co., Ltd.3,038$10.7K0.00%
GF Fund Management Co. Ltd.1,914$6.81K0.00%
Hurley Capital, LLC1,569$5.62K0.00%
Park Circle Co1,500$5.34K0.00%
R Squared Ltd1,010$3.60K0.00%
Comprehensive Financial Planning, Inc.1,000$3.56K0.00%
IFP Advisors, Inc10$360.00%

Sold out (22)

Institutions that held Aquestive Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (2)

Institutions that held Aquestive Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AQST in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Chartwell Investment Partners, LLC107,550$535.0K
Raymond James Financial Services Advisors, Inc.16,032$79.8K